Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to TNF Inhibitors: 52-Week Results from a Phase 3 Study Genovese, M. C., Combe, B., Kremer, J., Adams, D., Lee, C., Kerr, L., Nash, P. WILEY. 2017

View details for Web of Science ID 000411824106473